Development of a Telephone-Delivered Acceptance and Commitment Therapy Intervention for People Living with HIV who are Hazardous Drinkers.
Development of a Telephone-Delivered Acceptance and Commitment Therapy Intervention for People Living with HIV who are Hazardous Drinkers.
复制标题
DOI：
10.1007/s10461-022-03649-x
复制
发表时间：
2022-09
影响因子：
4.4
通讯作者：
Maisto SA
中科院分区：
文献类型：
--
作者：
Woolf-King SE;Firkey M;Foley JD;Bricker J;Hahn JA;Asiago-Reddy E;Wikier J;Moskal D;Sheinfil AZ;Ramos J;Maisto SA
艾滋病毒感染者（PWH）的酒精使用越来越被认为是艾滋病毒护理的重要组成部分。跨诊断治疗，如接受和承诺疗法（ACT），目标是多种心理健康和物质相关问题共同的核心过程，在心理和行为健康共病率高的艾滋病毒治疗环境中可能是理想的。在随机临床试验（RCT）之前，本研究的总体目标是系统地调整最初为戒烟开发的基于ACT的干预措施，使其适用于饮酒达到危险水平的PWH。与ADAPT-ITT模型一致，适应过程分几个阶段进行，包括结构化的团队会议，与PWH（N = 13）的三个焦点小组讨论，与HIV提供者（N = 10）的深入访谈，以及干预培训，监督和最终RCT实施的标准化操作程序的开发。这里描述的程序为早期行为RCT的透明报告提供了一个模板。
Alcohol use among people living with HIV (PWH) has been increasingly recognized as an important component of HIV care. Transdiagnostic treatments, such as Acceptance and Commitment Therapy (ACT), that target core processes common to multiple mental health and substance-related problems, may be ideal in HIV treatment settings where psychological and behavioral health comorbidities are high. In advance of a randomized clinical trial (RCT), the overall objective of this study was to systematically adapt an ACT-based intervention originally developed for smoking cessation, into an ACT intervention for PWH who drink at hazardous levels. Consistent with the ADAPT-ITT model, the adaptation progressed systematically in several phases, which included structured team meetings, three focus group discussions with PWH (N = 13), and in-depth interviews with HIV providers (N = 10), and development of standardized operating procedures for interventionist training, supervision, and eventual RCT implementation. The procedures described here offer a template for transparent reporting on early phase behavioral RCTs.
登录
查看更多内容
影响因子：
4.6
作者：
Brown, Jennifer L.;DeMartini, Kelly S.;Sales, JessicaM.;Swartzendruber, Andrea L.;DiClemente, Ralph J.
通讯作者：
DiClemente, Ralph J.
影响因子：
4.4
作者：
Batchelder AW;Foley JD;Wirtz MR;Mayer K;O'Cleirigh C
通讯作者：
O'Cleirigh C
影响因子：
4.2
作者：
Czajkowski, Susan M.;Powell, Lynda H.;Charlson, Mary E.
通讯作者：
Charlson, Mary E.
DOI：
10.1097/qai.0000000000000679
发表时间：
2015-10-01
期刊：
Journal of acquired immune deficiency syndromes (1999)
影响因子：
--
作者：
Chander G;Hutton HE;Lau B;Xu X;McCaul ME
通讯作者：
McCaul ME
DOI：
10.1111/acer.14336
发表时间：
2020-05-22
期刊：
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH
影响因子：
--
作者：
Ferguson, Tekeda F.;Theall, Katherine P.;Molina, Patricia E.
通讯作者：
Molina, Patricia E.